FNY Managed Accounts’s American Renal Associates Holdings, Inc ARA Stock Holding History

FNY Managed Accounts’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$2K	Buy	+134	New	+$2.64K	﹤0.01%	461

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

FNY Managed Accounts's ARA Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in American Renal Associates Holdings, Inc (ARA) in Q1 2018: 134 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #461 among its holdings.

82 funds tracked by Wall St. Rank hold ARA as of Q1 2018.

FNY Managed Accounts held 134 shares of American Renal Associates Holdings, Inc worth $2K as of Q1 2018.
American Renal Associates Holdings, Inc was a new FNY Managed Accounts position in Q1 2018.
American Renal Associates Holdings, Inc made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #461 holding.
82 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.